Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Scientific Reports|October 29, 2020
Masking terminal neo-epitopes of linear peptides through glycosylation favours immune responses towards core epitopes producing parental protein bound antibodiesRobert Pon, Anne Marcil, Wangxue Chen, et al.
Infection and Immunity|August 2, 2012
Modulation of toxin production by the flagellar regulon in Clostridium difficileAnnie Aubry, Greg Hussack, Wangxue Chen, et al.
Nucleic Acids Research|July 2, 2026
Biosynthesis of glycosylated 5-hydroxycytosine in the DNA of diverse virusesYan-Jiun Lee, Jianjun Li, Cécilia Sobieski, et al.
Infection and Immunity|November 22, 2005
A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccineSusan Twine, Mona Byström, Wangxue Chen, et al.
Infection and Immunity|February 6, 2019
Contribution of Active Iron Uptake to Acinetobacter baumannii PathogenicityFederica Runci, Valentina Gentile, Emanuela Frangipani, et al.
Veterinary Microbiology|June 6, 2006
Production of a D-glycero-D-manno-heptosyltransferase mutant of Mannheimia haemolytica displaying a veterinary pathogen specific conserved LPS structure; development and functionality of antibodies to this LPS structureSusan M Logan, Wangxue Chen, Annie Aubry, et al.
Vaccine|June 13, 2019
Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in miceAbenaya Muralidharan, Marsha S Russell, Louise Larocque, et al.
Scientific Reports|November 11, 2018
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infectionAbenaya Muralidharan, Marsha Russell, Louise Larocque, et al.
Antibiotics (Basel, Switzerland)|June 21, 2020
Characterization of Extremely Drug-Resistant and Hypervirulent Acinetobacter baumannii AB030Manu Singh, P Malaka De Silva, Yasser Al-Saadi, et al.
Vaccines|February 13, 2020
In vitro Production and Immunogenicity of a Clostridium Difficile Spore-Specific BclA3 Glycopeptide Conjugate VaccineAnnie Aubry, Wei Zou, Evguenii Vinogradov, et al.
Pageof 14